REQUEST A DEMO
Total
USD $0.00
Search more companies

Acton Pharma Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Acton Pharma Private Limited Profile Updated: April 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Acton Pharma Private Limited is an enterprise located in India, with the main office in West Delhi. It operates in the Pharmaceutical and Medicine Manufacturing sector. The enterprise was incorporated on May 15, 2012. There was a net sales revenue increase of 28.01% reported in Acton Pharma Private Limited’s latest financial highlights for 2024. A growth of 48.15% was recorded in its total assets. The net profit margin of Acton Pharma Private Limited decreased by 1.46% in 2024.

Legal Address
49A, Navyug Appartments Ground Floor, F-Block, Vikaspuri
West Delhi; Delhi; Postal Code: 110018

Contact Details: Purchase the Acton Pharma Private Limited report to view the information.

Basic Information
Registered Capital:
Purchase the Acton Pharma Private Limited report to view the information.
Financial Auditors:
Purchase the Acton Pharma Private Limited report to view the information.
Incorporation Date:
May 15, 2012
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Acton Pharma Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
28.01%
Total Operating Revenue
30.63%
Operating Profit
12.88%
EBITDA
12.97%
Net Profit/Loss for the Period
16.77%
Total Assets
48.15%
Total Equity
32.31%
Operating Profit Margin
-2.87%
Net Profit Margin
-1.46%
Return on Equity (ROE)
-3.25%
Quick Ratio
-1.93%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?